Bayer

Cara Care is a digital health platform focused on improving gut health through an app designed for patients with chronic gastrointestinal issues. The application enables users to track their dietary habits, including custom dishes and food items from an extensive database, while also recording symptoms such as pain, bloating, and emotional states. This comprehensive approach allows individuals to identify patterns and correlations between their diet and digestive health, empowering them to take control of their well-being. With a user base exceeding 700,000 patients globally, Cara Care combines behavioral, microbial, and nutritional data to offer a holistic alternative to traditional medication for digestive disorders.

Food Banks Canada is a national charitable organization dedicated to helping Canadians living with food insecurity.

Blackford Analysis Ltd. specializes in software solutions that enhance the comparison of medical images, thereby saving clinicians time and improving productivity in healthcare settings. Founded in 2010 and based in Edinburgh, the company offers products such as the Blackford Workflow Server, which integrates into hospital IT frameworks, and the Blackford Smart Localizer, designed for seamless comparison of imaging studies within existing systems. These tools enable users to conduct comparisons with a single click, typically resulting in time savings of 10% to 20%. Blackford’s technology employs advanced algorithms and multi-core processing to facilitate rapid registration of scans from various sources. The company partners with multiple imaging system providers and has expanded its reach by collaborating with organizations outside diagnostic imaging to enhance their offerings. Blackford Analysis has experienced significant growth, with sales offices in both the UK and the United States, and continues to develop bespoke image processing solutions to meet diverse healthcare needs.

Targenomix is a target identification firm that utilizes a systems biology approach to research, integrating molecular biology, cell biology, genetics, biochemistry, metabolomics, and transcriptomics with advanced data integration and computational biological solutions. The company focuses on identifying the mode of action of lead molecules within biological systems, providing valuable insights to agrochemical, pharmaceutical, and biotech sectors. By employing this interdisciplinary research methodology, Targenomix aims to offer unique opportunities for organizations working with small molecules and more complex ingredients, including biologicals. This distinctive approach positions Targenomix as a leader in its field, addressing the needs of companies seeking to understand and develop new compounds.

OME Health is a client health support and practice management platform that focuses on enhancing individual wellness through personalized nutrition regimes and health coaching. The platform utilizes data from smart devices, food diaries, and app interactions to enable real-time monitoring of clients' progress. In addition to providing direct-to-consumer wellness programs that incorporate genetic, gut microbiome, and blood testing, OME Health also offers an online health assessment and a complimentary fitness tracker. This comprehensive approach not only helps individuals achieve their health goals but also reduces the administrative burden on health professionals, allowing them to focus on client needs and professional development.

Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.

Noria is a research and development company managed by experienced radiopharmaceutical development leaders and focused on the development of novel targeted alpha therapeutics and theranostic agents.

Elly Health Inc. develops innovative audio companion software designed to support patients, healthcare providers, and organizations. The company's flagship product, Elly, serves as an empathetic audio companion for individuals managing chronic diseases. By leveraging technology, Elly motivates and offers guidance from experts and contributors, enhancing the support system for those living with chronic conditions. Founded in 2019 and based in Los Angeles, California, Elly Health aims to improve patient experience and engagement in healthcare.

Asklepios BioPharmaceutical is a biotechnology company focused on developing adeno-associated virus (AAV) gene therapies for genetic disorders and rare diseases. The company utilizes proprietary AAV technology and has established comprehensive manufacturing capabilities, alongside a pipeline that includes clinical-stage programs targeting Pompe disease and congestive heart failure, as well as a preclinical portfolio addressing neuromuscular and central nervous system disorders. Additionally, Asklepios has out-licensed clinical indications for conditions such as hemophilia and Duchenne muscular dystrophy. Its gene therapy platform encompasses an advanced cell line manufacturing process and a diverse library of AAV capsids and promoters. Founded in 2001 and headquartered in Research Triangle Park, North Carolina, Asklepios BioPharmaceutical aims to enhance patient outcomes through innovative genetic medicine solutions.

Care/of is a healthcare technology company dedicated to simplifying consumer health, starting with a fully personalized vitamin pack. Their first product is a vitamin experience delivered monthly to consumers, personalized to the individual customer's unique body, lifestyle, values, and health goals. Care/of is a New York City based technology company founded on the basis of honesty, quality, and personalization.

KaNDy Therapeutics is a biotechnology company based in Stevenage, United Kingdom, focused on developing non-hormonal treatments for various menopausal symptoms, including hot flashes and nighttime awakenings. Established in 2017, the company is known for its drug NT-814, which addresses moderate to severe post-menopausal vasomotor symptoms. By providing non-hormonal therapies, KaNDy Therapeutics aims to alleviate the debilitating effects of hormone-related conditions in women. As a subsidiary of Bayer Aktiengesellschaft, the company leverages its research and development capabilities to enhance the quality of life for patients experiencing these common symptoms.

Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its mobile application, Ouchie. This application provides targeted educational content and rewards for achieving functional milestones, fostering a support system for patients. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to enhance care quality while minimizing the burden on healthcare providers. By empowering patients with data and social support, Upside Health aims to improve outcomes for chronic pain sufferers and create revenue-generating opportunities for healthcare practices.

BioLum Sciences LLC, founded in 2015 and based in Dallas, Texas, focuses on developing innovative asthma management devices that enable patients to monitor airway inflammation. The company specializes in bioanalytical chemistry and medical device development, utilizing a chemiluminescent platform to measure biomarkers in exhaled breath condensate and blood samples. Their primary product, the BioSense Airway Monitoring Device (AMD), allows for at-home monitoring of lung function by measuring oxidative stress biomarkers without complicated breathing maneuvers. This technology not only aids patients in tracking their symptoms and medication efficacy but also provides physicians with vital data to optimize treatment plans. Additionally, BioLum’s blood analysis product offers a simple finger-prick test to assess nitric oxide levels and cardiovascular health. The company's initiatives extend to addressing chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure, supporting both clinicians and researchers in personalizing treatment strategies and improving patient outcomes.

Metagenomi, Inc. is a biotechnology company focused on developing gene editing systems aimed at treating genetic diseases. Founded in 2016 and based in Emeryville, California, Metagenomi utilizes metagenomics and machine learning to uncover novel genome editing technologies derived from previously uncharacterized organisms. The company's innovative discovery platform enables the creation of highly efficient and specific gene editing tools, including programmable nucleases, base editors, and advanced integration systems such as prime editing and CRISPR-associated transposases. By harnessing these naturally evolved systems, Metagenomi seeks to address a wide range of genetic mutations that traditional genome engineering approaches have struggled to target, with the ultimate goal of providing transformative therapies for patients globally.

BioSTL builds regional capacity and fosters collaborative efforts to advance innovation, entrepreneurship, and new company creation that capitalize on St. Louis’ world-class medical and plant biosciences. Through its work, BioSTL promotes economic growth and regional prosperity.

Aparito Limited is a health technology company based in Wrexham, United Kingdom, that focuses on digitizing clinical trials and enhancing drug development. Founded in 2014, the company develops mobile applications and wearable devices designed for patient monitoring outside of hospital settings. Its Atom5™ eCOA platform is compliant with regulatory standards and supports patient-centric clinical trials by enabling the collection of real-time, patient-generated data through various methods such as video assessments, electronic patient-reported outcomes, and telemedicine. This approach facilitates continuous monitoring and provides valuable insights into patient health and disease progression, ultimately aiming to improve clinical trial outcomes and patient care. By allowing patients and their caregivers to participate in research from home, Aparito enhances accessibility and engagement in the clinical trial process across numerous countries and languages.

S-There is a company that has developed an innovative smart toilet device aimed at improving health monitoring. This passive medical device allows users to track their hydration levels and understand how environmental factors impact their hydration. Through a mobile application, S-There provides users with detailed insights into their hydration quality and trends, enabling them to make informed decisions about their health. By offering personalized feedback, the device aims to assist individuals in managing their hydration effectively and addressing chronic health issues.

The Muny is a community outdoor musical performance and recreation center. In this studio, singers may perform without accompaniment or may be accompanied by any instrumental combination, from piano to full orchestra. They inspire people to praise. Likewise, using the choir for congregational songs is a powerful prompt to help worshipers clearly hear the melody and join their voices as one.

CoverCress Inc. is a biotechnology company based in St. Louis, Missouri, focused on developing and commercializing field pennycress as an oilseed crop. Founded in 2013, the company aims to produce oil for industrial and renewable fuels, as well as meal for nutritious livestock feed. CoverCress specializes in crop breeding services that enhance soil cover during corn harvest and soybean planting, allowing farmers to maximize yields through sustainable agricultural practices. The company is dedicated to utilizing low-input methods to create a feedstock for low carbon intensity biofuels, contributing to more efficient and environmentally friendly agricultural solutions.

Sky Labs is focused on developing innovative wearable technology for continuous health monitoring, specifically targeting atrial fibrillation, a common but often undiagnosed heart condition. The company’s flagship product, the Cardio Tracker (CART), is a cuffless, ring-type device that allows users to monitor their heart health effortlessly by simply wearing it on their finger. This device is designed to be comfortable and practical for daily use, being waterproof and dustproof so that it can be worn continuously, even during activities like showering. The CART operates without requiring user intervention, automatically detecting and recording instances of atrial fibrillation to provide users with real-time health data accessible via a smartphone app. This capability not only helps users manage their heart health but also assists healthcare professionals in diagnosing atrial fibrillation based on the data collected. Sky Labs is currently engaged in clinical trials with Seoul National University Hospital to validate the device's performance and is collaborating with Bayer to enhance its healthcare offerings. The initial target market includes atrial fibrillation patients in Finland, with a broader goal of reaching millions globally.

Boragen Inc. is a biotechnology company based in Durham, North Carolina, founded in 2015. The company specializes in developing multi-functional small molecule boron solutions for applications in crop protection, animal health, and human health. Boragen's product pipeline includes BAG8, a boron-based multisite fungicide aimed at crop protection, and BN2266, a fungicide that targets mRNA processing. Additionally, the company is working on a dual-function nematicide-fungicide for root protection and endo-parasiticides designed to overcome resistance. Boragen's innovative synthetic chemistry platform focuses on creating next-generation fungicides that support sustainable farming by minimizing the risk of fungicide resistance and reducing chemical usage while ensuring efficacy and performance.

Monsanto Company, based in St. Louis, Missouri, specializes in providing agricultural products aimed at enhancing crop production while promoting sustainable practices. The company operates through two main segments: Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment offers a variety of row crop seeds, including corn, soybean, cotton, and canola, as well as vegetable seeds like tomato and pepper, marketed under well-known brands such as DEKALB and Seminis. It also develops biotechnology traits that help farmers manage pests and weeds. The Agricultural Productivity segment focuses on manufacturing and selling herbicides for agricultural and residential use, including the widely recognized Roundup brand. Monsanto markets its products through various channels, including distributors and directly to farmers, and collaborates with other organizations to advance agricultural research and development. The company was previously known as Monsanto Ag Company and adopted its current name in 2000. As of 2018, Monsanto operates as a subsidiary of Bayer Aktiengesellschaft.

proPlant Gesellschaft für Agrar- und Umweltinformatik

Precision agriculture web-based software to analyze productivity of your fields. Zoner.ag is a software solution created by IntelMax Corp. to organize, store, and analyze information in precision agriculture. The system carries out the analysis of satellite images, aerial imagery, yield monitor data and soil EC, terrain and other georeferenced data. In addition, Zoner.ag provides detailed real-time information about the weather in each field and allows for crop disease forecasting. Our technology helps to increase yield by 8-10%, efficiency of use of mineral fertilizers by up to 40%, and saves 20-30% of pesticides. More info at http://zoner.ag/

DIHON PHARMACEUTICAL GROUP CO., LTD., Ltd., located in Kunming National New & High-Tech Industrial Development Zone, is a Sino-American joint venture founded in 1997 by Great Eastern Enterprises Inc. of US and the majority shareholder Yunnan Dihon Pharmaceutical Group Co., Ltd. of China. Dihon’s predecessor was Yunnan Dihon Natural Pharmaceutical Factory founded in 1993.

Merck Consumer Care (MCC) is the allergy-treatment Claritin and decongestant Afrin.

Algeta ASA, an oncology company, focused on developing targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. Its lead product includes radium-223 dichloride, which completed Phase III clinical trial to treat castration-resistant prostate cancer with bone metastases. The company is also developing alpha-emitter thorium-227 that is in the preclinical phase linked to tumor-targeting molecules to form targeted thorium conjugates. It has an agreement with Bayer Pharma AG for the development and commercialization of radium-223 worldwide. The company was formerly known as Anticancer Therapeutic Inventions AS and changed its name to Algeta ASA in 2003. Algeta ASA was founded in 1997 and is headquartered in Oslo, Norway.

AgraQuest specializes in biological and low-chemical pest management solutions aimed at enhancing agricultural practices and ensuring food safety. The company is dedicated to developing, manufacturing, and marketing effective biological products that control pests and diseases while promoting sustainable agriculture. With a focus on environmentally responsible practices, AgraQuest's offerings are derived from renewable, bio-based materials, distinguishing them from conventional pesticides that rely on synthetic chemicals. The company's Agrochemical and BioInnovations Divisions provide a range of innovative technologies for seed treatment, food safety, and post-harvest disease control, as well as applications in animal health, human nutrition, and home and garden care. AgraQuest employs a direct sales force in the NAFTA crop protection markets and collaborates with distributors and partners globally to extend its reach. By prioritizing sustainability and efficacy, AgraQuest aims to transform the agrochemical industry and support growers with best-in-class pest control solutions.

Direvo Industrial Biotechnology GmbH, founded in 2008 and based in Cologne, Germany, specializes in developing and marketing biology-based products and processes for non-pharmaceutical industries. The company focuses on providing bio-based solutions in clean energy, clean chemistry, and biomass conversion markets by leveraging its expertise in enzymes and microbes. Its BluZy platform features technologies tailored for the grain ethanol industry, enhancing both the nutritional value of by-products and the efficiency of ethanol production processes. Additionally, the BluServ platform offers automated high-throughput screening for protein and strain engineering, while the BluCon technology facilitates the conversion of non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with major industry players and is privately owned, with investments from various equity partners and private investors.

Icon Genetics GmbH is an agricultural biotechnology company based in Halle, Germany, specializing in the discovery and development of biopharmaceuticals and protein products using green plants as production hosts. Founded in 1999, the company focuses on creating innovative production platforms and product prototypes for various markets, including pharmaceuticals, animal health, and chemical biotechnology. Its offerings encompass a range of advanced technologies, such as Transgene Operating Systems, which feature methods for nuclear transformation and plastid transformation to enhance the production of specialty proteins. Additionally, Icon Genetics provides systems like magnICON for rapid gene assembly and high-throughput expression, lexICON for DNA barcoding, and rubICON for hybrid seed production. The company also develops antibodies and vaccines. Icon Genetics has subsidiaries in both Germany and the United States and operates as a subsidiary of Denka Company Limited.

Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations. It provides microarray platforms for sensitive and quantitative protein profiling, and signaling pathway analysis by reverse protein arrays. Its products include ZeptoREADER, a microarray reader for Zeptosens planar wave guide technology; ZeptoMARK protein microarray chips and ZeptoCARRIER for various data points, which are split into arrays. The company also offers proteinarray services, including protein profiling for various samples, such as cell lines, tissues, microdissected cells, and depleted serums; and assay development. In addition, it provides training services, technical and applications support, and technical service and maintenance. The company’s products are used in various applications, including biomarker/target discovery and validation, cell-based screening, mode of action profiling, selectivity profiling, and toxicology investigation. Its customers include pharma research and development companies, biotech companies, and academic institutions. Zeptosens was founded in 2002 and is headquartered in Wilderswil, Switzerland.

yet2.com provides intellectual property consulting and licensing services to world-class clients around the globe. Yet2.com Inc. and its online marketplace were founded in 1999 to promote Open Innovation, with original investments from Siemens, Bayer, Honeywell, DuPont, Procter & Gamble, Caterpillar, and NTT Leasing. The privately held company has offices in the United States, Europe, and Japan. The web site now has over 120,000 registered marketplace users including many of the Fortune 500 and over 16,000 smaller technology companies. In addition to its core team, yet2.com has created a wide network of Open Innovation partners covering many of the technology-rich countries around the world as well as relationships with open innovation organizations, technical expert networks, SME networks, technical magazines, online technical communities, and technology brokers. These provide market-wide access to technologies and needs in countries such as Russia, China, India, Korea, Brazil, South Africa, Japan, the US, and the EU.